IP Library Granted Patent US 10,208,339
Granted Patent B2
US 10,208,339 · App. 15/047,259 · Granted Feb 19, 2019

Systems and methods for whole genome amplification

Inventors: Alain-Albert Mir (Redwood City, CA); Thomas David Schaal (San Francisco, CA); Jude Dunne (Menlo Park, CA); Maithreyan Srinivasan (Palo Alto, CA)
Assignee: TAKARA BIO USA, INC.
C12Q1/686C12N9/1252C12Q1/6844C12Q1/6874C12Y207/07007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,208,339
App. No.
15/047,259
Granted
Feb 19, 2019
Kind
B2
Abstract

Provided herein are systems and methods for whole genome amplification and sequencing. In particular, provided herein are systems and methods for detection of nucleic acid variants (e.g., rare variants) in limited samples.

Claims (18)

1. A method of whole gene amplification (WGA), the method comprising:

a) combining:

a sample of genomic DNA template;

a phi29 polymerase;

nucleic acid primers; and

dNTPs;

into a reaction mixture under conditions sufficient for genomic DNA template-directed extension of the nucleic acid primers; and

b) amplifying the extended nucleic acid primers in the reaction mixture with a thermostable DNA polymerase to generate amplified whole genome DNA,

wherein said combining and amplifying are performed in a single vessel.

2. The method of claim 1 , wherein said sample of genomic DNA is a single cell sample.

3. The method of claim 1 , wherein said sample of genomic DNA is a plurality of cells.

4. The method of claim 1 , further comprising the step of detecting one or more nucleic acid variants in said amplified whole genome DNA.

5. The method of claim 1 , wherein said method further comprises the step of performing a nucleic acid sequencing assay on said amplified whole genome DNA.

6. The method of claim 1 , wherein said amplification is conducted in a volume of 35 to 500 nL.

7. The method of claim 1 , wherein at least a subset of said primers are specific for a nucleic acid target of interest.

8. The method of claim 1 , wherein at least a subset of said primers comprises a sample barcode, molecular barcode, label, or tag sequence.

9. The method of claim 1 , wherein said vessel is a well of a microfluidic chip comprising a plurality of wells.

10. The method of claim 9 , wherein each of said wells comprises a distinct nucleic acid primer.

Assignments (2)
MERGER Recorded Sep 19, 2017
From: WAFERGEN, INC.
To: TAKARA BIO USA, INC.
Reel/Frame 043631/0517 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2016
From: MIR, ALAIN-ALBERT; SCHAAL, THOMAS DAVID; DUNNE, JUDE; SRINIVASAN, MAITHREYAN
To: WAFERGEN, INC.
Reel/Frame 038330/0457 →
Continuity (2)
Provisional Application 62118131 · Feb 19, 2015
Related Publication 20160304935A1 · Oct 20, 2016